Claritas

SINGAPORE and LONDON, May 28, 2023 (GLOBE NEWSWIRE) -- Claritas HealthTech and PwC today announced that they will collaborate on the rollout, deployment, and support of a suite of medical image enhancement and AI diagnostic software…

Cincinnati, OH, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Claritas®, a data-driven company that helps marketers achieve superior ROI, and Affinity Solutions, the leading consumer purchase data platform focused on outcome-based solutions, have…

LONDON and SINGAPORE, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Claritas HealthTech (“Claritas”), a healthcare technology company specializing in medical image enhancement and Artificial Intelligence (AI) assisted diagnostic tools, announces…

Cincinnati, OH, July 19, 2022 (GLOBE NEWSWIRE) -- Onovative, an automated marketing technology software provider, announced a partnership today with Claritas to integrate P$YCLE Premier segmentation data into their Core iQ platform.…

SAN FRANCISCO, CA and TORONTO, ON, April 05, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") today announced that the Australian Human Research Ethics…

SAN FRANCISCO, CA and TORONTO, ON, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: KLY and OTC: KALTF) (the "Company" or "Claritas") today announced that it has signed a Letter of Intent dated January 17,…

SINGAPORE and LONDON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Claritas HealthTech Pte. Ltd. (“Claritas”), a healthcare technology company specializing in innovative deep-learning and advanced image enhancement to improve the quality and…

SAN FRANCISCO, CA and TORONTO, ON, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today announced that it has entered into a License Amendment dated…

SAN FRANCISCO and TORONTO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today announced that the journal Scientific Reports, has published a…

SAN FRANCISCO and TORONTO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: CLAS.V) (the "Company" or "Claritas") today announced that it has entered into a binding Letter of Intent (the…